The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
Open accessAbstract
OBJECTIVE: To investigate if a central cholinesterase inhibitor will reduce falling frequency in subjects with Parkinson disease (PD) with advanced postural instability. BACKGROUND: Falling due to postural instability is a significant problem in advancing PD, and is minimally impacted by dopaminergic therapy. Anticholinergic medications increase falling in the elderly. Further, CNS cholinergic neuron loss occurs in PD. We hypothesized that acetylcholine augmentation may reduce frequent falling in subjects with PD. METHODS: We enrolled 23 subjects with PD who reported falling or nearly falling more than 2 times per week. In a randomized, placebo-controlled, crossover design, subjects were given 6 weeks of donepezil or placebo with a 3-week washout between phases. The primary outcomes were daily falls and near falls reported on postcards. Secondary outcomes included scores on the Activities of Balance Confidence Scale, Berg Balance Scale, Clinical Global Impression of Change, Folstein Mini-Mental State Examination, and the motor section of the Unified Parkinson's Disease Rating Scale. RESULTS: Fall frequency per day on placebo was 0.25 ± 0.08 (SEM) compared with 0.13 ± 0.03 on donepezil (p < 0.05). The frequency of near falls was not significantly different between phases. The secondary outcomes did not differ; however, there was a trend to improvement on the subject-completed Global Impression of Change scale. CONCLUSIONS: Subjects with PD fell approximately half as often during the 6 weeks on donepezil than on placebo. Larger trials of cholinergic augmentation are warranted in subjects with PD with frequent falls. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that donepezil (maximum 10 mg per day) significantly reduced the number of falls in patients with PD (0.13 falls/day, SEM = 0.03) than when taking placebo (0.25 falls/day, SEM = 0.08, p = 0.049).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Measuring balance in the elderly: validation of an instrument.
Berg, K., Wood-Dauphinée, S., Williams, J. I., & Maki, B. E. (1992) · PubMed · Cited by 2,961
The Activities-specific Balance Confidence (ABC) Scale
Powell, L. E., & Myers, A. M. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.1.m28 · Cited by 2,869
Attention and the control of posture and gait: a review of an emerging area of research
Woollacott, M., & Shumway-Cook, A. (2002) · Gait & Posture · doi:10.1016/s0966-6362(01)00156-4 · Cited by 2,690
Rivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Postural Orientation and Equilibrium
Horak, F. B., & Macpherson, J. M. (1996) · Comprehensive Physiology · doi:10.1002/cphy.cp120107 · Cited by 1,006
Self-citationProspective assessment of falls in Parkinson's disease
Bloem, B. R., Grimbergen, Y. A. M., Cramer, M., Willemsen, M., & Zwinderman, A. H. (2001) · Journal of Neurology · doi:10.1007/s004150170047 · Cited by 865
Stefani, A., Lozano, A. M., Peppe, A., Stanzione, P., Galati, S., Tropepi, D., Pierantozzi, M., Brusa, L., Scarnati, E., & Mazzone, P. (2007) · Brain · doi:10.1093/brain/awl346 · Cited by 807
Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study
Wood, B. H. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.721 · Cited by 700
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Gait and Cognition: A Complementary Approach to Understanding Brain Function and the Risk of Falling
Montero‐Odasso, M., Verghese, J., Beauchet, O., & Hausdorff, J. M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04209.x · Cited by 1,052
Fox, S. H., Katzenschlager, R., Lim, S., Barton, B., de Bie, R. M. A., Seppi, K., Coelho, M., Sampaio, C., & on behalf of the Movement Disorder Society Evidence‐Based Medicine Committee (2018) · Movement Disorders · doi:10.1002/mds.27372 · Cited by 1,002
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Metadata
- Authors
- Chung, K. A., Lobb, B. M., Nutt, J. G., & Horak, F. B.
- Venue
- Neurology
- Published
- 2010-10-05
- Volume
- 75
- Issue
- 14
- Pages
- 1263-1269
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2031041233
- Cited by
- 252
- References
- 38
- FWCI
- 45.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. https://app.cochat.ai/papers/10.1212/wnl.0b013e3181f6128c
- The paper
- Chung, K. A., Lobb, B. M., Nutt, J. G., & Horak, F. B. (2010). Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e3181f6128c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.